This Practice Point commentary discusses the paper by Dhar and colleagues, which compared outcomes between two cohorts of patients with muscle-invasive bladder cancer who received either 'limited' ...

Investigators proposed that lymph node dissection should be included as part of radical cystectomy for patients with NMIBC. Lymph node dissection during radical cystectomy (RC) may improve oncologic ...

Whether extended lymphadenectomy is associated with improved disease-free and overall survival, as compared with standard lymphadenectomy, among patients with localized muscle-invasive bladder cancer ...

Analysis of the results of intravesical perfusion therapy combined with immediate or non-immediate hematoporphyrin intravesical perfusion photodynamic therapy (PDT) after TURBT for NMIBC. This is an ...

Chemoradiation or surgery with pelvic lymph node dissection and perioperative chemotherapy may still effectively treat nonmetastatic node-positive bladder cancer. Among patients receiving treatment ...

Effectiveness and safety of first-line atezolizumab in locally advanced or metastatic urothelial cancer: The IMFLAME study. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...

Extended lymphadenectomy did not improve disease-free or overall survival compared to standard lymphadenectomy in muscle-invasive bladder cancer patients. Higher perioperative morbidity and mortality ...

Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...

According to Jim C. Hu, senior author of a new paper published in European Urology, “bladder neck preservation [during robotic-assisted laparoscopic radical prostatectomy (RALP)] produces an earlier ...

Treatments for bladder cancer include surgery, chemotherapy, and radiation therapy. Newer treatment options include immunotherapy and targeted therapy. Doctors may administer medications directly into ...